Categories Technology

Alphabet’s Verily teams up with ResMed to tackle sleep apnea

The healthcare-based subsidiary of Alphabet (GOOGL), Verily, and medical equipment company ResMed (RMD) will join forces to form a JV that will focus on the treatment of sleep apnea and other sleep-related breathing disorders. The partnership aims to create a software that helps in detecting, diagnosing and treating the potentially serious types of sleep disorders.

Verily has entered into several partnerships ever since it became an independent subsidiary of Alphabet in 2015, including pharma giants Johnson & Johnson (JNJ), Sanofi, and Gilead Sciences (GILD). Verily now aims at getting more initiatives into hospitals. Hence, the unit has strengthened its leadership team and has appointed several industry experts to its Board.

The latest JV will combine ResMed’s sleep expertise and Verily’s advanced health data analytics technologies to study the health and financial impacts of undiagnosed and untreated sleep apnea. ResMed has spent years researching sleep apnea, which is a significant health issue in the US. This disorder is said to affect nearly 22 million Americans, most of which remain undiagnosed.

Related: Google’s research firm outstrips pharma rivals in heart disorder prediction

Verily has several promising ongoing projects including controlling the spread of Zika virus, developing glucose-monitoring contact lenses, creating wristbands that helps spot indicators of cancer and heart diseases and many more.

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top